Bile duct cyst type V (Caroli's disease): surgical strategy and results  by Lendoire, Javier et al.
ORIGINAL ARTICLE
Bile duct cyst type V (Caroli’s disease): surgical strategy and results
JAVIER LENDOIRE1, PABLO BARROS SCHELOTTO1, JUAN ALVAREZ RODRI´GUEZ2,
FERNANDO DUEK1, CARLOS QUARIN1, VERO´NICA GARAY1, MARCELO AMANTE1,
EDUARDO CASSINI3 & OSCAR IMVENTARZA1
1Liver Transplantation Unit and 2Division of General Surgery, Hospital Dr Cosme Argerich and 3Division of General
Surgery, Hospital Italiano de La Plata, Buenos Aires, Argentina
Abstract
Background. Caroli’s disease (CD) is a benign congenital disorder characterized by segmental cystic dilatation of the
intrahepatic biliary ducts. Therapeutic strategy includes medical treatment, percutaneous, endoscopic or surgical drainage
of the affected bile ducts, liver resection or transplantation. The aim of this study was to analyse the results and long-term
follow-up of a consecutive series of patients who underwent surgical treatment for CD. Patients and methods. Between 1995
and 2005, 10 patients were surgically treated for CD. Variables evaluated were: age, gender, clinical presentation, diagnostic
procedures, percutaneous and surgical treatments, histopathological analysis and outcome. Results. The average age of the
patients was 45.8 years. Recurrent cholangitis was the main clinical manifestation (70%). In unilateral CD a liver resection
was performed in nine patients (left lateral sectionectomy in seven, left hepatectomy in one and right hepatectomy in one).
In bilateral disease a cholecystectomy, duct exploration, hepaticojejunostomy and liver biopsy of both lobes were performed.
Average follow-up was 60 months. All the patients are alive and free of symptoms without recurrence in the remnant liver.
Discussion. Liver resection is the preferred therapeutic option for unilateral CD, demonstrating good results in long-term
follow-up. In bilateral disease, hepaticojejunostomy could be considered as an alternative or a previous step to liver
transplantation, which still remains the ultimate option.
Key Words: liver surgery, Caroli’s disease, Caroli’s syndrome, bile duct cyst type V
Introduction
Caroli’s disease (CD) is a benign congenital disorder,
characterized by unilobar or bilobar segmental cystic
dilatation of the intrahepatic biliary tract. It corre-
sponds to type V choledochal cyst as classified by
Todani et al. [1]. The first report was by Todd in 1818
but Jaques Caroli in 1958 defined the disease precisely
with its different types [24]. Autosomal recessively
inherited in most cases, the pathogenesis of the
dilatation in the intrahepatic biliary tree is considered
to be due to a lack of normal involution of the ductal
plate [5]. Two different kinds of disease are described:
a simple one (CD) and a complex type associated with
congenital hepatic fibrosis (Caroli’s syndrome, CS)
[68].
Clinical symptoms of CD include recurrent cho-
langitis, right upper quadrant abdominal pain and
jaundice, development of stones and liver abscess,
usually followed by a progressive loss of quality of life
and death due to uncontrolled sepsis [9]. In CS,
portal hypertension and hepatic fibrosis are respon-
sible for the clinical manifestations. Various renal
disorders have been described in association with
these liver diseases, including autosomal polycystic
kidney disease, medullary sponge kidney and medul-
lary cystic disease [10].
Ultrasound, computed tomography (CT) scan,
percutaneous transhepatic cholangiography, endo-
scopic cholangiopancreatography (ERCP) and mag-
netic resonance cholangiopancreatography (MRCP)
are performed to establish the diagnosis [1113].
Treatment of CD depends on the localization and
extension of the disease. Endoscopic, percutaneous or
surgical drainage of the bile ducts, liver resection and
orthotopic liver transplantation (OLT) appear to be
different options for the treatment of patients with
symptomatic CD [1417].
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The aim of this retrospective study was to analyse
the clinical features of the disease and the results of
surgical treatment in 10 adult patients with CD
treated at the Liver Transplantation and Surgical
Divisions of the Hospital Dr C. Argerich, Buenos
Aires and Hospital Italiano of La Plata, Argentina.
Patients and methods
The case notes of 10 patients treated at Hospital Dr
Cosme Argerich and Hospital Italiano of La Plata
with a diagnosis of CD, between October 1995 and
December 2005, were reviewed retrospectively. Pa-
tients were selected from the Liver Transplantation
and Surgical Division prospective computerized da-
tabase and were verified using records of each patient.
Data covering demographic features, clinical symp-
toms, biochemical and radiologic examinations, prior
therapeutic interventions, surgical procedure, compli-
cations, duration of hospital stay and long-term out-
come were analysed. Histopathological analysis was
performed in all patients. Diagnosis of cholangitis was
based on the presence of intermittent right upper
quadrant pain, intermittent fever, transient jaundice
and increased biochemical markers. Postoperative
follow-up consisted of laboratory tests, CA 19-9 levels
and ultrasound, performed every 3 months during the
first year and then every 6 months.
Results
Seven patients were males. The median age was
45.8 years (range 2782). Clinical presentation con-
sisted of recurrent cholangitis complicated by intra-
hepatic calculi in seven patients, recurrent acute
pancreatitis in one and abdominal pain in two. Four
of the patients had previously undergone an open
cholecystectomy for symptomatic gallstones.
In all patients the diagnosis was established pre-
operatively by means of an abdominal ultrasound and
CT scan that revealed the unilateral or bilateral
dilated intrahepatic bile ducts, hepatolithiasis and
cystic cavities or abscess (Figures 1 and 2). MRCP
and ERCP were carried out in four and three patients,
respectively. Owing to recurrent cholangitis, three
patients required percutaneous biliary drainage (Fig-
ure 3). Nine patients had unilobar disease and one
had bilobar compromise. The time range between the
onset of symptoms and treatment after diagnosis was
260 months. There was no associated polycystic
kidney disease or portal hypertension. At resection
all patients were free of septic complications.
Surgical technique
Liver resection was performed by standard technique.
Intraoperative ultrasound was routinely performed.
Intermittent Pringle manoeuvre was only required
in one patient. After operation all patients were
monitored in the intensive care unit. No patients
required blood replacement in the perioperative
period. Considering the extent of the disease, the
surgical procedures were as follows. (A) Monolobar
disease: left lateral sectionectomy in seven patients,
left hepatectomy in one and right hepatectomy in
another. Additional procedures performed were bile
duct exploration with T tube in two patients and
biopsy of the remnant liver in four. (B) Bilobar
disease: cholecystectomy, intrahepatic bile duct ex-
ploration with multiple stone removal, liver biopsy
Figure 1. Ultrasound in bilateral Caroli’s disease. Multiple stones
in dilated intrahepatic bile ducts.
Figure 2. CT in bilateral Caroli’s disease. Severe dilatation of the
bile ducts.
Figure 3. Percutaneous transcatheter cholangiography in bilateral
Caroli’s disease. Dilated bile ducts with stones and abscess.
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and end-to-side Roux-en-Y hepaticojejunostomy with
stent drainage in one patient.
Complications
There were two complications in one patient, a wound
dehiscence and an intra-abdominal abscess from the
cut surface treated by surgical drainage and repaired
by means of a polypropylene mesh. There were no
biliary complications. The perioperative mortality rate
was 0%.
Pathological analysis
Macroscopically the excised livers presented saccular
or fusiform dilatation of segmental or principal bile
ducts with visible stones. Histology showed biliary
hamartomas, biliary ramifications and periductal
granulomatous reaction. There was no patient with
congenital hepatic fibrosis (CS) or cirrhosis. Biopsies
of the remnant livers showed normal histology. In the
case with bilobar compromise, CD characteristics and
moderate fibrosis were demonstrated.
Follow-up
Median follow-up was 60 months (range 12148). All
patients are alive, free of symptoms. No patient had
recurrence of CD. The patient with hepaticojejunost-
omy presented laboratory tests, CA 19-9, ultrasound
and cholangioMRCP in the normal range at
63 months. A control liver biopsy demonstrated no
changes in the degree of fibrosis from the time of
surgery.
Discussion
CD, a congenital disorder of the intrahepatic bile
ducts due to a ductal plate malformation, integrates
the ‘fibrocystic’ group, characterized by a variable
degree of fibrosis and ectasia [5]. The level of the
intrahepatic biliary tree affected by the ductal plate
malformation is in relation with the pathogenesis of
different kind of diseases. In CD, the large and
proximal intrahepatic bile ducts are affected, in CS
and congenital hepatic fibrosis the smaller ones and in
polycystic liver disease and von Meyenburg complexes
the more peripheral interlobular ducts [5,18]. The
finding of an unbalanced translocation between chro-
mosomes 3 and 8 suggests that loss of distal 3p and/or
gain of 8q is of importance in the pathogenesis of CD
[19]. It is an autosomal recessive disease and is
associated with polycystic kidney disease and hepatic
fibrosis [20]. It corresponds to the type V bile duct
cyst as incorporated by Todani et al. in Alonso-Lej et
al. classification [1,21,22]. Considered a quite rare
entity, with 150 cases reported in the literature,
several series include not only patients with CD but
also with CS [10,14,17,23]. Our population consisted
only of patients with CD and the average duration of
symptoms was in accordance with other reports
[6,14].
Bacterial cholangitis is the most frequent presenta-
tion and life-threatening complication of CD
[4,8,12,24]. Usually caused by Gram-negative bacilli,
it has a recurrent course and despite different
antibiotic associations the medical treatment is often
not satisfactory. It is documented by the presence of
stone obstruction with bile stasis, dilated biliary ducts
containing purulent material and mixed bacterial
infections [25]. Cholangitis may appear sponta-
neously but can also appear following invasive diag-
nostic and therapeutic procedures. In the present
study three patients required percutaneous biliary
drainage before definitive treatments. Acute pancrea-
titis was also reported by other authors [26,27]. In a
multi-institutional study from Argentina, acute pan-
creatitis was found in 6% of patients with hepato-
lithiasis and Pimentel et al. reported it in 23% of 26
patients with CD [24].
Although ultrasound and CT are widely used to
investigate patients with CD, MRCP presents advan-
tages to depict the entire biliary tree [13,28]. Guy et
al. identified three main patterns of CD in MRCP: (a)
multiple cystic ectasias connected with fusiform
dilatations, (b) isolated fusiform dilatations with
multiple calculi and (c) solitary dilatation of the left
bile ducts with cysts and multiple calculi [29].
Treatment of CD depends on the clinical features
and localization of the biliary abnormality.
When the disease is localized to one hepatic lobe,
most commonly the left, hepatectomy or sectionect-
omy must be indicated [6,8]. Symptomatic relief after
partial hepatectomy was complete and permanent in
100% of patients in this series. Ulrich et al. have
treated 39 patients with CD in a 12-year period. In 32
of them, they performed the same resective procedure
[17]. Gillet et al. showed that in patients with
unilateral CD, numerous interventional procedures
(endoscopic, percutaneous or surgical) were per-
formed before a definitive treatment [6].
Dysplasia of the biliary epithelium generated by bile
stasis and chronic inflammation can develop a malig-
nant transformation to cholangiocellular carcinoma in
514% of patients with CD [11,30,31]. A higher
incidence is reported in unilateral cases [6,30].
In reference to the bilateral CD we present a
33-year-old man treated by Roux-en-Y hepaticojeju-
nostomy. Bilio-digestive anastomosis after thorough
cleaning of the biliary tree is an option and has been
advocated by different authors as a first stage in CD
with bilateral involvement [4,8,12,14,17,22]. OLT
has been suggested as a possible therapeutic ap-
proach, principally in patients with CS associated
with portal hypertension and in cases with recurrent
cholangitis due to bilateral disease when other med-
ical treatments have been ineffective [10,16,25,32]. It
avoids the development of cholangiocarcinoma that
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with the exception of study protocols is considered a
contraindication to transplantation [25,33]. However,
in the UNOS Database in a 17-year period (1988
2005) only 95 patients were transplanted for CD and
CS. Concerns around OLT in this disease are the
choice of the appropriate time for transplant and the
problem of exposing young healthy individuals to the
risks and consequences of the transplant and immu-
nosuppression itself. In our study follow-up, the
patient with bilateral disease showed normal liver
function and non-progressive fibrosis at 63 months.
Medical treatment with ursodeoxycholic acid could be
useful in patients with bilateral CD, as was demon-
strated by Ros et al. with a total and partial stone
dissolution of 15% and 45%, respectively [34].
In conclusion, our results demonstrate that surgical
resection is the best curative option for patients with
unilateral symptomatic CD. Left lateral sectionect-
omy was the most common resection in this series. In
bilateral disease hepaticojejunostomy could be an
optional treatment that offers long-term survival and
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